| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |